AppLovin (NASDAQ: APP) shares plunged more than 17% on Thursday after the mobile advertising platform’s second-quarter results came in just below expectations — a first stumble for a company that had been one of Wall Street’s most celebrated AI growth stories. Revenue for Q2 2026 hit $1.924 billion, up an impressive 53% year-over-year, but fell roughly $11 million short of the $1.935 billion analyst consensus. Adjusted EBITDA also landed below the company’s own guidance range, sending the stock to a new 52-week low near $108.
CEO Adam Foroughi was candid on the earnings call: the miss “came down to timing.” AppLovin had planned to roll out machine-learning model improvements that would have boosted ad performance in the quarter, but the deployment was delayed. Importantly, management says those improvements are now live. Consumer-facing ad spend on the platform actually surged 28% above its Q4 2025 peak — an internal metric that suggests underlying demand remains robust. For Q3 2026, AppLovin guided revenue of $2.055 billion to $2.085 billion, representing 46%–48% growth year-over-year. Adjusted EBITDA guidance of $1.71–$1.74 billion implies an ~83% EBITDA margin, only one percentage point below Q2’s level. The Q3 revenue midpoint of $2.07 billion came in 0.6% below analyst estimates, which compounded the negative market reaction.
For retail investors, AppLovin’s selloff raises a pointed question: is this a buying opportunity or a signal that the AI ad-tech thesis is cracking? The bull case rests on the fact that a one-quarter model delay is a timing issue, not a business breakdown — the 53% revenue growth, near-record margins, and 48% Q3 guidance target all suggest the engine is intact. The bear case is valuation: even after the 17% drop, AppLovin trades at a premium multiple, and any further guidance softness could attract more selling. Investors who believe management’s explanation may find the dip worth watching, but the stock’s elevated starting point demands conviction. Watch Q3 results closely — if AppLovin delivers on its $2.07 billion midpoint or beats it, the thesis reasserts itself decisively.
